Post-immunization adverse human papilomavirus events in teenagers

Abstract

To assess the occurrence of post-vaccine adverse events in adolescents related to the human papillomavirus quadrivalent vaccine 6, 11, 16 and 18 (recombinant) through the National Immunization Program Information System Post-Vaccination Adverse Events of the Program Area Health Coordination 5.1 from the Basic Health Units. The sample consisted of adolescents between 9 and 17 years old. Retrospective, exploratory, descriptive, and quantitative study from November 1, 2016 to June 1, 2019. The study analyzed 22 reporting forms, 19 of adverse events following vaccination and 3 Immunization Errors (IS). Adverse events in adolescents are related to anxiety and fear of vaccination occurring in the administration of the first dose of the predominant male HPV vaccine occurring within the first 30 minutes after immunobiological administration. In this research, the most frequent adverse events were classified as non-serious, with evolution to cure without sequelae, related to manifestations such as pallor, hypotension, fainting and syncope.